GLP-1 Drugs Improve Outcomes After Elective Abdominal Surgery | Research

The takeaway

GLP-1 RA use was associated with improved outcomes and reduced complications following elective abdominal surgery, extending perioperative GLP-1 benefits to abdominal procedures.

Better abdominal surgery
GLP-1 drug users had improved outcomes after abdominal surgery — the anti-inflammatory benefits extend to yet another surgical specialty

What the researchers found

GLP-1 RA: improved outcomes and reduced complications after elective abdominal surgery, extending perioperative benefits to this common surgical category.

Why it matters

Abdominal surgery is one of the most common surgical categories. GLP-1 drugs improving outcomes would affect millions of patients.

How the study worked

Study evaluating GLP-1 RA effects on outcomes and complications following elective abdominal surgery.

What this study cannot tell us

Observational. Cannot prove causation. Aspiration risk remains a separate consideration.

How to read the evidence

Observational surgical outcome study.

When this study was published

Published in 2025.

The bigger picture

GLP-1 drugs appear to improve surgical outcomes across spine, joint, cardiac, and now abdominal surgery — suggesting a universal perioperative benefit.

Questions still open

Should GLP-1 drugs be started preoperatively for all elective abdominal surgery?
Which specific abdominal complications are most reduced?
Would GLP-1 drugs improve emergency abdominal surgery outcomes?

Common questions

Do GLP-1 drugs help with abdominal surgery?

This study found improved outcomes and fewer complications in GLP-1 drug users after elective abdominal surgery — the drugs' anti-inflammatory effects may help surgical healing.

Should I keep taking my GLP-1 drug before surgery?

The surgical outcome data supports continuing. The main perioperative concern (aspiration risk) is managed by anesthesia teams separately from surgical outcome benefits.

Read the original research

Effect of Glucagon-like Peptide-1 Receptor Agonists on Outcomes and Complications Following Arthroscopic Rotator Cuff Repair: A Matched-Cohort Analysis.

Orthopaedic journal of sports medicine, 14(2), 23259671251412408

View on PubMed ↗Publisher’s paper ↗

Citation

Lauck, Bradley J; Colson, Charles B; Bank, Nicholas C; Trasolini, Nicholas A; Waterman, Brian R; Churchill, Jessica; Reynolds, Alan W. (2026). Effect of Glucagon-like Peptide-1 Receptor Agonists on Outcomes and Complications Following Arthroscopic Rotator Cuff Repair: A Matched-Cohort Analysis.. Orthopaedic journal of sports medicine, 14(2), 23259671251412408. https://doi.org/10.1177/23259671251412408